Skip to main content

Immunological Enhancement Blend

No sources yet

An index of captured practitioner sources, not a completed evidence summary. Unchecked figures and empty sections are omitted. See the library review status.

Source summary generated November 6, 2026; this date does not indicate completed review.

ImmunityAliases: Immunological Enhancement, immune blend
Track your own protocol free →

Quotes from three independent practitioners, with their sources. Research context only.

What it is and how it works

From the published literature on Immunological Enhancement Blend; the papers are listed at the end. Research summary, not a recommendation.

What it is

Immunological Enhancement is a vendor injectable blend of three compounds: glutathione (a three-amino-acid peptide made by every cell and its main internal antioxidant), ascorbic acid (vitamin C) and zinc sulfate (a salt that supplies the trace mineral zinc). All three are normal nutrients or body chemicals, and only glutathione is a peptide. No peer-reviewed study of the blend itself was found as of 2026-11-06; the papers below concern its components.

How it works

Vitamin C donates electrons, which makes it an antioxidant and a required helper for enzymes that build collagen and regulate genes; it supports the skin and airway barriers and the function of white blood cells, and deficiency (scurvy) impairs immunity. Zinc acts as a signalling ion inside immune cells, moved in and out by dedicated zinc transporter proteins, and deficiency produces a pro-inflammatory, poorly functioning immune system. Glutathione keeps the inside of cells chemically reduced (neutralizing reactive oxygen molecules) and also blocks pigment production in skin cells, which is why it is promoted for skin lightening. Supplements correct deficiency, but in people with normal levels the trials found small or no benefits, and giving the three together has not been tested.

What it has been studied for

  • Immune cell function and infection (vitamin C review)
  • Immune signalling and inflammation (zinc review)
  • Common cold prevention and duration (vitamin C Cochrane review)
  • Common cold duration (zinc lozenge individual-patient meta-analysis)
  • Sepsis in intensive care (intravenous vitamin C randomized trial)
  • Raising the body's glutathione stores (oral glutathione randomized trial)
  • Skin lightening and its safety (glutathione review)
  • Benefits and risks of high-dose intravenous vitamin C (systematic review)

Strength of the evidence

Human trialsEach component has randomized trials (vitamin C and zinc for colds, intravenous vitamin C in sepsis, oral glutathione), with modest or no benefit in people who are not deficient, and the blend itself has never been studied.

What the literature reports on safety

In a large randomized trial in septic intensive-care patients, intravenous vitamin C increased the combined risk of death or persistent organ dysfunction, and high-dose intravenous vitamin C can cause oxalate kidney injury and haemolysis (red-cell breakdown) in people with G6PD deficiency, so screening is advised. Adverse effects of intravenous glutathione used for skin lightening led the Philippines FDA to issue a public warning, and no glutathione injection is FDA-approved; ascorbic acid injection (for scurvy) and zinc sulfate injection (as a zinc source in intravenous nutrition) are FDA-approved products, but not for immune enhancement. Too much zinc over time can cause copper deficiency.

Key papers

  1. Vitamin C and Immune Function (opens in a new tab)

    Review · Carr AC, Maggini S · Nutrients (2017) · PMID 29099763

    Described how vitamin C supports barrier function and the activity of innate and adaptive immune cells, and how deficiency impairs immunity and increases susceptibility to infection.

  2. Zinc as a Gatekeeper of Immune Function (opens in a new tab)

    Review · Wessels I, Maywald M, et al. · Nutrients (2017) · PMID 29186856

    Described zinc as a signalling ion in immune cells controlled by zinc importer and exporter proteins, and how zinc deficiency drives a pro-inflammatory immune state.

  3. Glutathione as a skin whitening agent: Facts, myths, evidence and controversies (opens in a new tab)

    Review · Sonthalia S, Daulatabad D, et al. · Indian Journal of Dermatology, Venereology and Leprology (2016) · PMID 27088927

    Found no evidence that intravenous glutathione injections work for skin lightening and noted that their adverse effects led the Philippines FDA to issue a public warning.

  4. Vitamin C for preventing and treating the common cold (opens in a new tab)

    Review · Hemilä H, Chalker E · Cochrane Database of Systematic Reviews (2013) · PMID 23440782

    Regular vitamin C did not reduce how often people caught colds in the general population but modestly shortened them, and taking it only after symptoms began showed no consistent benefit.

  5. Zinc acetate lozenges for treating the common cold: an individual patient data meta-analysis (opens in a new tab)

    Review · Hemilä H, Petrus EJ, et al. · British Journal of Clinical Pharmacology (2016) · PMID 27378206

    Pooled patient data from three randomized trials found that zinc acetate lozenges shortened colds by roughly three days compared with placebo.

  6. Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit (opens in a new tab)

    Randomized trial · Lamontagne F, Masse MH, et al. · New England Journal of Medicine (2022) · PMID 35704292

    In adults with sepsis on vasopressors, intravenous vitamin C led to a higher risk of death or persistent organ dysfunction at 28 days than placebo.

  7. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione (opens in a new tab)

    Randomized trial · Richie JP Jr, Nichenametla S, et al. · European Journal of Nutrition (2015) · PMID 24791752

    Over six months in healthy adults, oral glutathione raised glutathione levels in blood cells, plasma and cheek cells, with levels returning to baseline a month after stopping.

  8. Clinical benefits and risks of high-dose intravenous vitamin C: a systematic review (opens in a new tab)

    Review · Alangari A, Arif J, et al. · Journal of Medicine and Life (2026) · PMID 41815850

    Concluded that evidence did not support routine high-dose intravenous vitamin C in sepsis and identified oxalate kidney injury and haemolysis in G6PD deficiency as its major risks.

Sources checked: PubMed/PMC (E-utilities esummary and abstracts on every PMID), FDA approval records for ascorbic acid injection (Ascor, NDA 209112) and zinc sulfate injection, written 2026-11-06.

No sources yet

None of the three teachers' sources we have indexed discuss Immunological Enhancement Blend yet. This page will fill in as sources are added.

Deeper guided audio lives on What Am I Appreciating Now (leaves this site, opens in a new tab). What Am I Appreciating Now is a separate site run by the same operator; it sells meditation and hypnosis sessions.

Disclaimer: for research purposes only

All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol.If your path includes peptides, you buy them yourself from an independent licensed provider through a member co-op; we take nothing. How independent access works.

Immunological Enhancement Blend — Hunter, Taylor, Bachmeyer | Reset Biology